Eur J Prev Cardiol. 2026 Jan 30:zwag055. doi: 10.1093/eurjpc/zwag055. Online ahead of print.
ABSTRACT
AIMS: Obesity, particularly visceral adiposity, is a key driver of cardiovascular mortality (CVM), yet conventional measures such as body mass index (BMI) inadequately capture fat distribution. The Body Roundness Index (BRI) is a novel anthropometric measure integrating waist circumference and height to better reflect body shape and visceral fat. This study examined the association between BRI and CVM in U.S. adults and across sociodemographic subgroups.
METHODS: We analyzed data from 31,351 adults (median age 43 yrs, 50% females) aged >20 years in NHANES 1999-2018, excluding those with prior cardiovascular disease or cancer. BRI was computed using a validated equation and categorized into quintiles (Q3 as reference). The primary outcome was CVM; secondary outcomes included all-cause, heart disease, and cerebrovascular mortality. Weighted Cox proportional hazards and restricted cubic spline (RCS) models evaluated associations after adjustment for demographic, behavioral, and clinical factors. Subgroup and sensitivity analyses tested consistency and effect modification.
RESULTS: During a median follow up of 10.1 years (IQR: 5.3-14.9 years), 883 cardiovascular deaths occurred. In fully adjusted models, participants in the highest BRI quintile had a 54% higher risk of CVM (HR, 1.54; 95% CI, 1.13-2.08; p=0.006) versus Q3. This risk remained high even among those with normal BMI. RCS analysis indicated a modest U-shaped association. Stronger effects were observed among middle-aged adults (45-64 years) and those with higher educational attainment.
CONCLUSIONS: Higher BRI is independently associated with increased cardiovascular mortality, particularly among middle aged adults and those with normal BMI, underscoring its potential as a practical, noninvasive tool for cardiovascular risk stratification. Incorporating BRI into clinical and public health assessment may improve identification of individuals at elevated risk.
PMID:41615252 | DOI:10.1093/eurjpc/zwag055